Jamani, mambo ya biashara tuyaache kwenye biashara na ya siasa tuyaachie huko. Sidhani kama ni vizuri kuchanganya mambo haya mawili.
Tatizo hapa ni kuingiza ya siasa kwenye biashara and vice versa.
ARVs that the firm was set up to produce. Photo/FILE
InterChem Pharma Ltd, the Moshi-based pharmaceutical firm owned by media mogul Reginald Mengis younger brother Benjamin, has been placed under receivership over a large debt accrued from Barclays Bank Tanzania Ltd.
The firm, which three years ago acquired a $6 million loan for setting up an anti-retroviral (ARV) drug manufacturing plant in Tanzania, will go under the hammer next year.
Bank sources told The EastAfrican in Dar es Salaam last week that the firm acquired additional investment from Barclays under a debenture agreement and mortgaged its plant in Moshi to the bank.
Barclays Bank Tanzania has already appointed Charles Rwechungura and Dr Alex Nguluma to be receivers and managers of the firm, which faces a mountain of debt owed to various creditors.
According to Mr Rwechungura and Dr Nguluma, the firms assets and business are being offered for sale by competitive tender to recover the loan.
The two receiver managers were on December 27, 2008, expected to take possession of all properties owned by the firm under the banks instructions after the company failed to honour its debts.
The bank source said that InterChem Pharma Ltd also borrowed some $10 million from the bank and other sources for setting up a penicillin-products manufacturing facility within a maximum period of two years.
InterChem, which was founded in 1987, is a Tanzanian pharmaceutical manufacturing company and was owned jointly by Reginald Mengi and his brother Benjamin Mengi, who is the chairman of the firm.
The project envisaged expansion of the existing tablets and capsule line, establishing a new penicillin plant (liquids, dry powder, tablets, and capsules) as well as establishing a new line for the production of tabs and capsules for HIV.
Foreign collaboration was sought in the form of joint-venture partnership, buy-back arrangement and/or equipment purchase to facilitate implementation of the project.
The company was incorporated in 1983. It manufactures liquids, tablets, capsules, creams, ointments, dry powders, external preparations and veterinary medicines.
Source: The East Africn
Kunguni,
Mbona tunakuwa wavivu wa kufikiri?kwa suala dogo kama hili tunaingiza siasa ili iweje?kwa mtu aliyekopa benki kama Baclays ambayo siyo mali ya serikali.Je unahisi ni vyema kuhusisha suala hili na suala la kufilisiwa kwa mengi(Unavyohisi?)
Hata kama tuna mapenzi ya kweli kwa Mfanyabiashara Mzawa kama Mengi ,tusiwe wajinga kiasi cha kuona hata kama kakosa basi iwe sawa.Hapa naona tunapoelekea ni kupotea na kumezwa kwa mawazo ya mtu mmoja!
Tulishalizungumza hili muda Mrefu,Huyu Mzee wa kichaga mambo yake si shwari hivyo sasa anatafuta sympath kwa watanzania ili apewe ridhaa flani kwa malengo flani.
Time will tell